Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19

NCT04820803 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

OTHER: ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE
OTHER: PLACEBO

Sponsor

Rosa Tarrago

Collaborators

[object Object]